Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott suing Impax Labs over generic TriCor
Yahoo/AP
Saturday, October 31, 2009 - 10:54am
tags:
Abbott Laboratories, Impax, TriCor
Sanofi CEO: Animal-Biz Combo With Merck ‘More Likely Than Not’
Wall St. Journal
Saturday, October 31, 2009 - 10:53am
tags:
Merck, Sanofi
Shrugging Off the Side Effects
Motley Fool
Saturday, October 31, 2009 - 10:52am
tags:
Lilly CEO Lechleiter Calls for Repair of the 'Engine of Biopharma Innovation'
Yahoo/PR NewsWire
Saturday, October 31, 2009 - 10:50am
tags:
biotech
It's Not As Frightening As It First Appears (Mylan)
Motley Fool
Saturday, October 31, 2009 - 10:49am
tags:
Mylan
Of One-Time Gains and Pipelines
Motley Fool
Saturday, October 31, 2009 - 10:48am
tags:
Amgen Drug May Increase Stroke Risk in Some: Study
CNBC
Saturday, October 31, 2009 - 10:46am
tags:
Amgen, Aranesp
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
Yahoo/PR NewsWire
Saturday, October 31, 2009 - 10:45am
tags:
Byetta, Amylin, Eli Lilly, type 2 diabetes
GTx’s stock slides before conference call
bizjournals.com
Saturday, October 31, 2009 - 10:43am
tags:
GTx, prostate cancer, Acapodene
15 states sue Amgen alleging kickback scheme
Yahoo/AP
Saturday, October 31, 2009 - 10:42am
tags:
Amgen
Warner Chilcott closes $3.1 billion buyout of Procter & Gamble's drug unit
Yahoo/AP
Friday, October 30, 2009 - 10:59am
tags:
Proctor & Gamble, M&A, Warner Chilcott
Novartis not licensing Idenix's hepatitis C drug
Yahoo/AP
Friday, October 30, 2009 - 9:59am
tags:
Novartis, Idenix, hepatitis C
Biotech Mailbag: The Reason(s) for This Selloff
TheStreet.com
Friday, October 30, 2009 - 9:57am
tags:
biotech, selloff, Gilead Sciences, Vertex Pharmaceuticals, BioDelivery Sciences, Human Genome Sciences, Oncothyreon, Immunogen
China launches biotech VCs, new tech stock market
Fierce Biotech
Friday, October 30, 2009 - 9:56am
tags:
China
Human Genome Faces Binary Event
Minyanville
Friday, October 30, 2009 - 9:54am
tags:
Human Genome
Biopharma Deals of the Week
InVivo
Friday, October 30, 2009 - 9:23am
tags:
Sanofi, Micromet, Cephalon, BioAssets, GSK, Supergen, Astellas, Medivation
Simcere Gains Majority Control of Vaccine Subsidiary
Seeking Alpha
Friday, October 30, 2009 - 9:22am
tags:
vaccines, Simcere
Pfizer, Then and Now: Shareholder Say On Executive Pay
WSJ Online
Friday, October 30, 2009 - 9:21am
tags:
Pfizer, executive pay, shareholders
AstraZeneca Pays Millions to Settle Seroquel Cases
NY Times, NY
Friday, October 30, 2009 - 9:18am
tags:
AstraZeneca, Seroquel, settlements, whistleblowers
Shorts Using Any Bad News They Can to Drive Spectrum Pharma Down
Seeking Alpha
Friday, October 30, 2009 - 9:05am
tags:
Spectrum Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.